TScan Therapeutics
TCRX
#10917
Rank
HK$85.39 M
Marketcap
HK$1.26
Share price
-4.40%
Change (1 day)
-83.29%
Change (1 year)

P/S ratio for TScan Therapeutics (TCRX)

P/S ratio as of November 2026 (TTM): 1.53

According to TScan Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.1577. At the end of 2026 the company had a P/S ratio of 8.90.

P/S ratio history for TScan Therapeutics from 2021 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20268.9058.82%
20255.61-90.33%
202458.0337.83%
202313.2380.36%
20222.76-74.01%
202110.6